Cell Pathways
Horsham
About Cell Pathways
Cell Pathways develops small molecule-based drugs for cancer treatment. The company has developed an apoptosis technology platform for the development of therapeutic agents for cancer. These can be used in combination with other chemotherapy drugs.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Funding stage: M&A
- Last round: Series Unknown (Jan 1990)
- Website: cellpathways.com
Industries & Categories
Health Care, Health Diagnostics, Medical, Oncology
Canonical: https://fsome.com/organization/cell-pathways-1176716 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.